Status:
COMPLETED
Effect of Combined Ultrasound-guided Subdeltoid Corticosteroid Injections and Physiotherapy in Treatment of Patients With Chronic Subacromial Bursitis
Lead Sponsor:
Shin Kong Wu Ho-Su Memorial Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Subacromial Bursitis
Subacromial Impingement Syndrome
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study is to investigate whether combination of ultrasound-guided subdeltoidcorticosteroid injection and physiotherapy is more effective than either treatment alone in treatment of patients with c...
Detailed Description
Chronic subacromial bursitis (SAB) is a common shoulder disorder characterized by chronic shoulder pain with a painful arc of motion, and/or pain on active or passive motions. The diagnosis of SAB req...
Eligibility Criteria
Inclusion
- shoulder pain for more than 1 month
- age ≥20 years old
- painful abduction or internal rotation with a visual analog scale (VAS) pain score ≥4
- the presence of a painful arc of motion or pain at the middle to terminal range of shoulder abduction or internal rotation with an empty or soft end feel
- positive shoulder impingement test (Neer test and/or Hawkin test)
- a reduction in pain of ≥40% on active shoulder abduction or internal rotation at the terminal range after injection of 3ml of 1%lidocain into the SASD bursa under US guidance.
Exclusion
- a history of uncontrolled chronic diseases, e.g., malignant neoplasms, blood dyscrasia, and serious infection
- previous surgery of the affected shoulder
- any evidence of a rotator cuff tear or tendinopathy, demonstrated by positive resistive tests andsonographic findings
- calcification of the rotator cuff, demonstrated by x-ray or sonographic findings
- the presence of arthritis, such asinflammatory arthritis(e.g., rheumatoid arthritis, seronegativespondyloarthropathy, or crystal-related arthropathy), osteoarthritis, frozen shoulder, subacromial spurs, or deformity of the acromion
- the presence of instability of the affected shoulder
- a previous fracture near the shoulder region
- the presence of cervical radiculopathy or myelopathy
- having received a corticosteroid or hyaluronic acid subacromial or shoulder joint injection in the past 3 months.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT03871465
Start Date
August 1 2018
End Date
July 31 2020
Last Update
November 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan